Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality
- PMID: 19675223
- PMCID: PMC2756852
- DOI: 10.1128/CVI.00183-09
Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality
Abstract
The influence of kinetic patterns of Candida albicans germ tube antibodies (CAGTA) on mortality was analyzed in six intensive care units. Statistically significant lower mortality rates were found in patients with patterns of increasing CAGTA titers who had been treated with antifungal agents. Thus, antifungal treatment should be considered when CAGTA titers are increasing in critically ill patients.
Similar articles
-
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.BMC Infect Dis. 2011 Mar 9;11:60. doi: 10.1186/1471-2334-11-60. BMC Infect Dis. 2011. PMID: 21388550 Free PMC article.
-
Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.J Microbiol Immunol Infect. 2020 Oct;53(5):778-784. doi: 10.1016/j.jmii.2019.02.001. Epub 2019 Mar 11. J Microbiol Immunol Infect. 2020. PMID: 30902614
-
Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.Mycopathologia. 2017 Aug;182(7-8):645-652. doi: 10.1007/s11046-017-0125-9. Epub 2017 Apr 4. Mycopathologia. 2017. PMID: 28378240
-
Diagnostic accuracy of Candida albicans germ tube antibody for invasive candidiasis: systematic review and meta-analysis.Diagn Microbiol Infect Dis. 2019 Apr;93(4):339-345. doi: 10.1016/j.diagmicrobio.2018.10.017. Epub 2018 Nov 6. Diagn Microbiol Infect Dis. 2019. PMID: 30552034
-
Candidemia in the critically ill patient.Int J Antimicrob Agents. 2008 Nov;32 Suppl 2:S83-5. doi: 10.1016/S0924-8579(08)70005-0. Int J Antimicrob Agents. 2008. PMID: 19013345 Review.
Cited by
-
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.Intensive Care Med. 2015 Aug;41(8):1424-32. doi: 10.1007/s00134-015-3922-y. Epub 2015 Jul 2. Intensive Care Med. 2015. PMID: 26134359
-
Anti-Candida Antibodies of Patients with Invasive Candidiasis Inhibit Growth, Alter Cell Wall Structure, and Kill Candida albicans In Vitro.Mycopathologia. 2024 Feb 7;189(1):16. doi: 10.1007/s11046-023-00819-w. Mycopathologia. 2024. PMID: 38324097 Free PMC article.
-
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.BMC Infect Dis. 2011 Mar 9;11:60. doi: 10.1186/1471-2334-11-60. BMC Infect Dis. 2011. PMID: 21388550 Free PMC article.
-
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.Infection. 2016 Apr;44(2):223-33. doi: 10.1007/s15010-015-0849-8. Epub 2015 Oct 16. Infection. 2016. PMID: 26475482
-
Biomarkers of fungal infection: Expert opinion on the current situation.Rev Esp Quimioter. 2020 Feb;33(1):1-10. doi: 10.37201/req/2260.2019. Epub 2019 Nov 14. Rev Esp Quimioter. 2020. PMID: 31729203 Free PMC article.
References
-
- Garey, K. W., M. Rege, M. P. Pai, D. E. Mingo, K. J. Suda, R. S. Turpin, and D. T. Bearden. 2006. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin. Infect. Dis. 43:25-31. - PubMed
-
- Iruretagoyena, J. R., P. Regulez, G. Quindós, and J. Pontón. 2000. Antibodies to Candida albicans germ tubes in two intensive care patients with invasive candidiasis. Rev. Iberoam. Micol. 17:93-96. - PubMed
-
- Montagnoli, C., S. Sandini, A. Bacci, L. Romani, and R. La Valle. 2004. Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis. Med. Mycol. 42:319-324. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical